Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs






